Left Ventricular Hypertrophy
📧 Sign up to get email alerts when something new happens for Left Ventricular Hypertrophy.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2011-05-10Clinical Trial Update: Aliskiren in Combination With Losartan Compared to Losartan on the Regression of Left Ventricular Hypertrophy in Overweight Patients With Essential Hypertension [Phase 3]
A Phase 3 trial comparing aliskiren added to losartan versus losartan alone evaluated regression of left ventricular hypertrophy in overweig…
-
CLINICAL_TRIALS trial_result · 2011-04-27Clinical Trial Update: Efficacy and Safety of Valsartan in Combination With Amlodipine Compared to Losartan Plus Hydrochlorothiazide in Patients With Hypertension and Left Ventricular Hypertrophy [Phase 3]
Phase 3 trial comparing valsartan plus amlodipine versus losartan plus hydrochlorothiazide in hypertensive patients with left ventricular hy…
-
FDA approval · 2011-03-30FDA Approved: LOSARTAN POTASSIUM — Supplemental Application (Alembic Pharmaceuticals Limited)
FDA approved a supplemental application for Losartan Potassium from Alembic Pharmaceuticals Limited, confirming approval of a generic produc…
-
CLINICAL_TRIALS trial_result · 2011-03-28Clinical Trial Update: Hypertension in Hemodialysis [NA]
A completed clinical trial investigating hypertension in patients on hemodialysis, with a focus on left ventricular hypertrophy.
-
CLINICAL_TRIALS trial_result · 2011-02-01Clinical Trial Update: A Safety and Efficacy Study for Epoetin Alfa in Pre-dialysis Subjects. [Phase 3]
A completed Phase 3 safety and efficacy trial of epoetin alfa in pre-dialysis patients with anemia due to kidney disease. The study, sponsor…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2010-10-22FDA Approved: LOSARTAN POTASSIUM — Supplemental Application (Quallent Pharmaceuticals Health LLC)
The FDA approved a supplemental application for Losartan Potassium submitted by Quallent Pharmaceuticals Health LLC.
-
FDA approval · 2010-10-06FDA Approved: LOSARTAN POTASSIUM — Original Application (Alembic Pharmaceuticals Limited)
FDA approved an original ANDA for Losartan Potassium from Alembic Pharmaceuticals Limited, enabling a generic version for hypertension and r…
-
CLINICAL_TRIALS trial_result · 2010-09-24Clinical Trial Update: Changes of Left Ventricular Mass and Cardiac Function in Patients With Active Acromegaly During Treatment With the Growth Hormone Receptor Antagonist Pegvisomant [Phase 4]
This Phase 4 trial update investigates changes in left ventricular mass and cardiac function in patients with active acromegaly who are trea…
-
CLINICAL_TRIALS trial_result · 2010-08-04Clinical Trial Update: The PRIMO II Study: Paricalcitol Injection Benefits in Renal Failure Induced Cardiac Morbidity in Subjects With Chronic Kidney Disease (CKD) Stage 5 [Phase 3]
A Phase 3 trial (PRIMO II) evaluated paricalcitol injections for renal failure–induced cardiac morbidity in CKD Stage 5 patients. The study …
-
CLINICAL_TRIALS trial_result · 2010-08-02Clinical Trial Update: Stenting of Renal Artery Stenosis in Coronary Artery Disease Study [Phase 3]
Phase 3 trial evaluating stenting for renal artery stenosis in patients with coronary artery disease; current status is unknown.
-
CLINICAL_TRIALS research · 2010-07-08Clinical Trial Update: Dallas Heart Study 2: Return Clinic Visit for the Dallas Heart Study Cohort
This clinical trial update reports completion of the Dallas Heart Study 2 return clinic visit for the Dallas Heart Study cohort.
-
CLINICAL_TRIALS trial_result · 2010-06-16Clinical Trial Update: Glutamate and Diastolic Function in Patients Undergoing Aortic Valve Repair [Phase 4]
Phase 4 clinical trial update examining the association between glutamate and diastolic function in patients undergoing aortic valve repair.
-
CLINICAL_TRIALS trial_result · 2009-11-09Clinical Trial Update: The CLEVER Study - Coreg And Left Ventricular Mass Regression [Phase 3]
Phase 3 study evaluating carvedilol (Coreg) for regression of left ventricular mass in left ventricular hypertrophy; results have been poste…
-
CLINICAL_TRIALS trial_result · 2009-07-29Clinical Trial Update: The SILVER Study: Systolic Hypertension Interaction With Left Ventricular Remodeling [Phase 2]
The SILVER Phase 2 trial evaluating the interaction between systolic hypertension and left ventricular remodeling has completed.
-
CLINICAL_TRIALS trial_result · 2009-06-30Clinical Trial Update: Effect of Angiotensin II Receptor Blockers (ARB) on Left Ventricular Reverse Remodelling After Aortic Valve Replacement in Severe Valvular Aortic Stenosis [Phase 3]
Phase 3 clinical trial evaluating whether angiotensin II receptor blockers improve left ventricular reverse remodeling after aortic valve re…
-
CLINICAL_TRIALS trial_result · 2008-03-04Clinical Trial Update: Long Term Effects of Enalapril and Losartan on Genetic Heart Disease
A completed NHLBI trial evaluates the long-term effects of enalapril and losartan on genetic heart disease, focusing on hypertrophic cardiom…
-
CLINICAL_TRIALS trial_result · 2008-03-04Clinical Trial Update: Factors Contributing to Increased Left Ventricle Size in Patients With Abnormally Enlarged Hearts
This NHLBI-sponsored clinical trial update examines factors contributing to increased left ventricular size in patients with abnormally enla…
-
CLINICAL_TRIALS trial_result · 2008-03-04Clinical Trial Update: Investigation Into the Use of Ultrasound Technique in the Evaluation of Heart Disease
Clinical trial update describes the investigation of ultrasound techniques for evaluating heart disease in conditions including hypertrophic…
-
CLINICAL_TRIALS trial_result · 2008-02-06Clinical Trial Update: Candesartan and Candesartan/ Hydrochlorothiazide in the Treatment of Patients With Hypertension and LVH
Clinical trial update on candesartan and candesartan/hydrochlorothiazide for essential hypertension with left ventricular hypertrophy; the s…